Goldman Sachs took its Imax [IMAX] rating to the equivalent of Neutral from Buy, and the price target to $17.9 from $15, in a research note dated 2021-01-25. That figure represents around a -3.14% discount from where the company’s shares closed on Friday. Other analysts also revised their coverage, with B. Riley Securities’s analysts reiterating the shares to “a Buy” rating in a research note to investors issued in mid-October. Meanwhile, Goldman had launched its coverage on IMAX with “Buy”, in a research note produced for clients on July 15, 2020. In addition, there was an upgrade from The Benchmark Company on April 28, 2020. The rater changed IMAX from “a Hold” to “a Buy”.
<h2>Is IMAX Corporation [NYSE: IMAX] a Good Buy Right Now?</h2>It should be noted that IMAX technical indicators for short, intermediate as well as long term progress have placed an overall average of 100% as Buy. The average signal changed from 100% Buy in the last week and compares with 100% Buy in the past month. Data from IMAX Corporation’s Trend Spotter indicated that the signals were Weakening. The stock current average is 0.87 million shares in the past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, the average trading volume was 0.84 million shares while the medium-term average advocated for 100% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 0.86 million shares.
<h3>IMAX Price Performance</h3>On Wall Street, IMAX Corporation [NYSE:IMAX] finished Friday’s session up 0.93% at $18.47. The stock went up to $18.495 at the same session while its lowest single-day price was $17.92. In the last five days, it saw a fall of about -2.43%, IMAX Corporation shares gained by almost 2.50% since the beginning of the year. However, the share price has dropped to as low as -5.69% below its one-year high. On 01/07/21, the company shares recorded $19.20, the highest single-day price it has got to in the last 52-weeks, and a 52-week low was seen on 01/04/21, the same year at $17.11. The company’s shares have inclined by 0.98% in the past year. The 50-day SMA achieved is $16.29 while the 200-day SMA is $13.28. Volume gained to 0.67 million from 0.45 million in the previous session.